Skip to content
★ Sign in to follow
Insider activity · 24 months0 buys3 salesCumulative net flow
Total declarations
15
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (5 ops.)
€189k

Latest filing published 03 Sept 2026 for Abbott Laboratories, €4,941.

Filing timeline

BuySale
John A. Mccoy Jr.

Insider track record

Disclosed buys
0
Disclosed sells
5

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

John A. Mccoy Jr.: trading record in brief

John A. Mccoy Jr. discloses dealings in Abbott Laboratories to SEC (Form 4). Between 1 September 2023 and 2 September 2026, the trades on record add up to 15 filings.

The open-market record consists of 5 sales worth €189k, with no purchase. Outside the open market, there are 10 share grants. In 2026 alone, the filings show no purchases and 2 sales.

The latest filing, published on 3 September 2026, reports a share grant of €4,941 in Abbott Laboratories. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to John A. Mccoy Jr.

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations13 total
  • ◆
    VICE PRESIDENT AND CONTROLLERExecutivesAbbott Laboratories
    5,739 USD0SEC
    52 shares@ US$110.36Common shares without par valueSEC:0001644207-26-000012:0
  • ▼
    VICE PRESIDENT AND CONTROLLERExecutivesAbbott Laboratories
    2,958 USD0SEC
    27 shares@ US$109.54Common shares without par valueSEC:0001644207-26-000012:1
  • ◆
    VICE PRESIDENT AND CONTROLLERExecutivesAbbott Laboratories
    132,769 USD21SEC
    1,142 shares@ US$116.2622.7% of flowCommon shares without par valueSEC:0001644207-26-000007:0
  • ▼
    VICE PRESIDENT AND CONTROLLERExecutivesAbbott Laboratories
    67,614 USD38SEC
    585 shares@ US$115.5811.6% of flowCommon shares without par valueSEC:0001644207-26-000007:1
  • ◆
    VICE PRESIDENT AND CONTROLLERExecutivesAbbott Laboratories
    0SEC
    5,373 shares0Common shares without par valueSEC:0001644207-26-000002:0
  • ◆
    VICE PRESIDENT AND CONTROLLERExecutivesAbbott Laboratories
    10,480 USD30SEC
    79 shares@ US$132.661.8% of flowCommon shares without par valueSEC:0001415889-25-023588:0
  • ◆
    VICE PRESIDENT AND CONTROLLERExecutivesAbbott Laboratories
    148,914 USD22SEC
    1,096 shares@ US$135.8728.9% of flowCommon shares without par valueSEC:0001415889-25-006768:0
  • ▼
    VICE PRESIDENT AND CONTROLLERExecutivesAbbott Laboratories
    77,652 USD39SEC
    562 shares@ US$138.1715.1% of flowCommon shares without par valueSEC:0001415889-25-006768:1
  • ◆
    VICE PRESIDENTExecutivesAbbott Laboratories
    0SEC
    4,038 shares0Common shares without par valueSEC:0001415889-25-005894:0
  • ◆
    VICE PRESIDENTExecutivesAbbott Laboratories
    5,890 USD11SEC
    52 shares@ US$113.271.1% of flowCommon shares without par valueSEC:0001415889-24-022826:0
  • ◆
    VICE PRESIDENTExecutivesAbbott Laboratories
    110,566 USD13SEC
    921 shares@ US$120.0520.6% of flowCommon shares without par valueSEC:0001415889-24-006409:0
  • ◆
    VICE PRESIDENTExecutivesAbbott Laboratories
    0SEC
    4,407 shares0Common shares without par valueSEC:0001415889-24-005101:0
  • ◆
    VICE PRESIDENTExecutivesAbbott Laboratories
    0SEC
    531 shares0Common shares without par valueSEC:0001415889-23-013035:0

13 of 13 declarations